Solesence, Inc. (SLSN)

NCM – Real vaqt narxi. Valyuta: USD

1.24

-0.26 (-17.33%)

Yopilishda: May 12, 2026, 4:00 PM EDT

11.05.2026

Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™

New platform technologies enable OTC-grade sensitive skin claims in previously inaccessible anhydrous formats and bring environmental protection deeper into the color cosmetics assortment

28.04.2026

Solésence To Report First Quarter 2026 Financial Results and Host a Conference Call on May 12

ROMEOVILLE, Ill., April 28, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the first quarter of 2026 after the market opens on Tuesday, May 12, 2026, and host a conference call and webcast on the same date.

27.04.2026

Solésence, Inc. Announces Appointment of New Independent Director

Marc James to Join Board of Directors and Serve on Audit, Compensation, and Nominating Committees ROMEOVILLE, Ill., April 27, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced the appointment of Marc James to its Board of Directors as an independent director, effective immediately.

24.04.2026

Zacks Initiates Coverage of SLSN With Underperform Recommendation

Discover why Zacks issues an "Underperform" rating for Solesence, being the first on Wall Street to initiate coverage on the stock. Learn how margin pressure, cash flow weakness, rising leverage and execution challenges are weighing on growth.

31.03.2026

Solesence, Inc. (SLSN) Q4 2025 Earnings Call Transcript

31.03.2026

Solésence Reports Fourth Quarter and Full-Year 2025 Financial Results

Full Year 2025 record revenue of $62.1 million ROMEOVILLE, Ill., March 31, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the fourth quarter and year ended December 31, 2025.

19.03.2026

Solésence To Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 31, 2026

ROMEOVILLE, Ill., March 19, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the fourth quarter and full year 2025 before the market opens on Tuesday, March 31, 2026, and host a conference call and webcast on the same date.

Videolar

No Data

There is no data to display

Press-relizlar

11.05.2026

Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™

New platform technologies enable OTC-grade sensitive skin claims in previously inaccessible anhydrous formats and bring environmental protection deeper into the color cosmetics assortment

27.04.2026

Solésence, Inc. Announces Appointment of New Independent Director

31.03.2026

Solésence Reports Fourth Quarter and Full-Year 2025 Financial Results

26.02.2026

Yoolie Park joins Solésence, Inc. as Vice President of Brand Partnerships

Park brings over 20 years of industry experience to expand innovation and drive brand partner growth ROMEOVILLE, Ill., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN) a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that it has appointed Yoolie Park as Vice President of Brand Partnerships.

Solesence, Inc. (SLSN)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Solesence, Inc. (SLSN)

Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™

Solésence To Report First Quarter 2026 Financial Results and Host a Conference Call on May 12

Solésence, Inc. Announces Appointment of New Independent Director

Zacks Initiates Coverage of SLSN With Underperform Recommendation

Solesence, Inc. (SLSN) Q4 2025 Earnings Call Transcript

Solésence Reports Fourth Quarter and Full-Year 2025 Financial Results

Solésence To Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 31, 2026

Videolar

No Data

Press-relizlar

Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™

Solésence, Inc. Announces Appointment of New Independent Director

Solésence Reports Fourth Quarter and Full-Year 2025 Financial Results

Yoolie Park joins Solésence, Inc. as Vice President of Brand Partnerships

Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™

Solésence To Report First Quarter 2026 Financial Results and Host a Conference Call on May 12

Solésence, Inc. Announces Appointment of New Independent Director

Zacks Initiates Coverage of SLSN With Underperform Recommendation

Solesence, Inc. (SLSN) Q4 2025 Earnings Call Transcript

Solésence Reports Fourth Quarter and Full-Year 2025 Financial Results

Solésence To Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 31, 2026

Videolar

No Data

Press-relizlar

Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™

Solésence, Inc. Announces Appointment of New Independent Director

Solésence Reports Fourth Quarter and Full-Year 2025 Financial Results

Yoolie Park joins Solésence, Inc. as Vice President of Brand Partnerships

Search stocks

Solesence, Inc. (SLSN)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Solesence, Inc. (SLSN)

Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™

Solésence To Report First Quarter 2026 Financial Results and Host a Conference Call on May 12

Solésence, Inc. Announces Appointment of New Independent Director

Zacks Initiates Coverage of SLSN With Underperform Recommendation

Solesence, Inc. (SLSN) Q4 2025 Earnings Call Transcript

Solésence Reports Fourth Quarter and Full-Year 2025 Financial Results

Solésence To Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 31, 2026

Videolar

No Data

Press-relizlar

Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™

Solésence, Inc. Announces Appointment of New Independent Director

Solésence Reports Fourth Quarter and Full-Year 2025 Financial Results

Yoolie Park joins Solésence, Inc. as Vice President of Brand Partnerships

Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™

Solésence To Report First Quarter 2026 Financial Results and Host a Conference Call on May 12

Solésence, Inc. Announces Appointment of New Independent Director

Zacks Initiates Coverage of SLSN With Underperform Recommendation

Solesence, Inc. (SLSN) Q4 2025 Earnings Call Transcript

Solésence Reports Fourth Quarter and Full-Year 2025 Financial Results

Solésence To Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 31, 2026

Videolar

No Data

Press-relizlar

Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™

Solésence, Inc. Announces Appointment of New Independent Director

Solésence Reports Fourth Quarter and Full-Year 2025 Financial Results

Yoolie Park joins Solésence, Inc. as Vice President of Brand Partnerships